Latest News and Press Releases
Want to stay updated on the latest news?
-
IMA401 achieved deep and durable responses in various indications, including melanoma and head and neck cancer, with an initial promising clinical signal observed in lung cancerIn head and neck...
-
NEWMEDIA.COM explores why AI Visibility Operating Systems are replacing fragmented marketing strategies in AI-driven discovery environments.
-
Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction in the...
-
LOS ANGELES, May 31, 2026 (GLOBE NEWSWIRE) -- Crypto markets have been moving with a speed that’s catching many traders off guard. What used to be steady trend cycles has shifted into sudden, sharp...
-
REDWOOD CITY, Calif., May 31, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...
-
WOBURN, Mass., May 31, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...
-
Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma Brenetafusp monotherapy resulted in a 6-month overall survival rate of 87% and disease...
-
SlimTide scam or legit? 2026 weight loss probiotic supplement pricing, ingredients, complaints, and buyer verification details reviewed.
-
CHICAGO, May 31, 2026 (GLOBE NEWSWIRE) -- NeuExcell Therapeutics today announced that Dr. Yulun Huang will present the first-in-human clinical study of NXL-004 for recurrent malignant glioma as...
-
Nokia CorporationManagers’ transactions31 May 2026 at 13:00 EESTNokia Corporation - Managers' transactions (Hanrahan) Transaction notification under Article 19 of EU Market Abuse...